<DOC>
	<DOCNO>NCT03054779</DOCNO>
	<brief_summary>Building finding investigator previous study , COMIT I , purpose COMIT II study supplement DEXA measurement body composition supplementary DEXA measurement visceral adipose tissue specifically target impact oleic acid consumption body composition primary objective . COMIT II also include analysis fatty acid ethanolamines ( FAEs ) precursor elucidate mechanism canola oil may modify body composition , measurement endothelial function , inflammatory , adiposity insulin sensitivity biomarkers , genetic analysis .</brief_summary>
	<brief_title>Canola Oil Multi-center Intervention Trial II</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<criteria>waist circumference ≥94 cm men ≥80 cm woman Elevated triglyceride ≥150 mg/dL ≤ 400 mg/dL Reduced HDL &lt; 40 mg/dL men &lt; 50 mg/dL woman Fasting glucose ≥ 100 mg/dl ≤ 126 mg/dL Elevated blood pressure systolic ≥130 and/or diastolic ≥85 mm HG [ Unmedicated participant upper limit Stage 1 Hypertension : systolic &lt; 160 and/or diastolic &lt; 100 mm HG participant must free end stage/target organ disease symptom ] [ BP medicate participant : acceptable long individual meet specify blood pressure range &lt; 140/90 mmHg , stable least 6 month ] Individuals thyroid** , kidney , liver disease [ Individuals thyroid disease whose blood value within normal limit stable ( medication ) past 6 month consider eligible ] Individuals diabetes mellitus Smokers Individuals consume &gt; 14 alcoholic beverage per week Individuals take lipid lower medication ( ex : cholestyramine , colestipol , niacin , cloribrate , gemfibrozil , probucol , HMG CoA reductase inhibitor ) least last 3 month Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>